{"filing":{"accession_number":"0001493152-26-027500","cik":"0001679628","ticker":"JUNS","company_name":"JUPITER NEUROSCIENCES, INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1679628/000149315226027500/form8-k.htm"},"events":[{"id":3853,"run_id":3377,"accession_number":"0001493152-26-027500","anchor_item_number":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses multiple compensatory arrangements under Item 5.02(e): (1) Amendment No. 3 to Alison Silva's employment agreement appointing her as Chief Operating Officer and President with a base salary increase to $340,200 and a one-time grant of 600,000 stock options; (2) stock option grants to independent non-employee directors (100,000 shares each); and (3) discretionary bonuses in the form of stock options to five executives (ranging from 259,231 to 747,783 shares) plus an additional 200,000-share grant to the CFO. These are material compensatory arrangements affecting named executives and directors.","company_name":"JUPITER NEUROSCIENCES, INC.","ticker":"JUNS","filing_date":"2026-06-05","items":null}],"classifications":[{"id":4878,"accession_number":"0001493152-26-027500","item_number":null,"item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses multiple compensatory arrangements under Item 5.02(e): (1) Amendment No. 3 to Alison Silva's employment agreement appointing her as Chief Operating Officer and President with a base salary increase to $340,200 and a one-time grant of 600,000 stock options; (2) stock option grants to independent non-employee directors (100,000 shares each); and (3) discretionary bonuses in the form of stock options to five executives (ranging from 259,231 to 747,783 shares) plus an additional 200,000-share grant to the CFO. These are material compensatory arrangements affecting named executives and directors.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:33:45.965014+00:00","company_name":"JUPITER NEUROSCIENCES, INC.","ticker":"JUNS","filing_date":"2026-06-05"}]}